In the ongoing legal battle between Apple and medical device maker Masimo, the fate of the Apple Watch Series 9 and Ultra Watch 2 hangs in the balance. However, there seems to be a glimmer of hope for Apple as U.S. Customs has approved a proposed redesign that may allow the company to avoid a sales ban.
To provide some context, Masimo had accused Apple of patent infringement related to the blood oxygen monitoring feature found in most Apple Watches, except the Apple Watch SE. In October, the U.S. International Trade Commission ruled in favor of Masimo, resulting in a temporary removal of the Watches from sale. Apple appealed the decision, leading to the return of the products to Apple Stores, at least for the time being.
